Skip to main content
. 2000 Jul 1;106(1):63–72. doi: 10.1172/JCI9586

Figure 6.

Figure 6

Effect of MR1 or CTLA4Ig treatment on cardiac allograft survival in STAT6–/– mice. Recipients were treated with MR1 (250 μg intraperitoneally) at the day of transplantation or with CTLA4Ig (250 μg intraperitoneally) on day 2. Untreated controls are shown by solid line. AP < 0.01.